CIK 0001980845 · <br>Emerging growth company
enGene Therapeutics Inc.
Sign in to watch- Ticker
- ENGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Oct 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (514) 332-4888
- Business address
- 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
- Former names
- enGene Holdings Inc.
Securities
- ENGN Common Stock Nasdaq
- ENGNW Warrants Nasdaq
- Open-market buys, last 90 days
- $10,051
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,051. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-31 | Forbion Growth Sponsor FEAC I B.V. 10% owner | Other acquisition · Warrant (Right to Buy) | +54,634 | 786,253 | ||
| 2023-10-31 | Forbion Growth Sponsor FEAC I B.V. 10% owner | Other acquisition · Warrant (Right to Buy) | +950,153 | 1,736,406 | ||
| 2023-10-31 | CHEUNG ANTHONY TZEYEW Chief Technology Officer | Grant or award | +49,933 | 49,933 | ||
| 2023-10-31 | Glickman Richard M Director | Grant or award | +24,555 | 24,555 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +1,341,790 | 1,341,790 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +44,647 | 44,647 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +348,686 | 348,686 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +83,816 | 83,816 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +1,077,386 | 1,077,386 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award | +152,974 | 152,974 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +114,945 | 114,945 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +3,825 | 3,825 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +38,301 | 38,301 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +9,207 | 9,207 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +145,603 | 145,603 | ||
| 2023-10-31 | BRUNK GERALD A Director | Grant or award · Warrants (right to buy) | +20,673 | 20,673 | ||
| 2023-07-07 | Nichols Alexander Julian Pres. & Chief Operating Ofc. | Grant or award · Stock Option (Right to Buy) | +101,924 | 101,924 | ||
| 2023-07-07 | CHEUNG ANTHONY TZEYEW Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +185,222 | 185,222 | ||
| 2023-07-07 | Hanson Jason David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +512,826 | 512,826 | ||
| 2023-07-07 | Sullivan James Crowley Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +118,509 | 118,509 |
Page 5 of 7 · 121 trades